Fall 2020 bioengineering graduate Megan Lohner says taking a job at Kalamazoo-based Pfizer was “a little bit of a 180” compared to her vision for her first post-college job. She had studied some biochemistry here at UM-Dearborn, but biomechanics and sports injuries were her primary passions. Lohner, who was a student-athlete, even did research in that area under Professor Amanda Esquivel. But as with many of us, the pandemic changed her calculations about what seemed most important. “For me, it’s always been about science and helping people,” Lohner says. “So when I saw this job at Pfizer, the idea of coming back to Kalamazoo, my hometown, and working on the vaccine that was going to help get us out of this just felt like the right thing to do.”
Since January, Lohner has been directly involved with the most groundbreaking part of Pfizer’s vaccine: It’s part of her job to dilute the concentrated mRNA to the proper levels before large batches of the vaccine are dispatched into tiny, life-saving vials. On the day to day, the feeling that they’re doing something “important for the country” is palpable at Pfizer. President Biden even visited recently to cheer them on, as has Governor Whitmer.